Literature DB >> 22339161

Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection.

Jun Hyong Ahn1, Sang Hyun Lee, Sohee Kim, Jungnam Joo, Heon Yoo, Seung Hoon Lee, Sang Hoon Shin, Ho-Shin Gwak.   

Abstract

OBJECT: Surgical spillage has been one of the causative factors for the development of leptomeningeal seeding (LMS) after resection of brain metastases. In this paper, the authors' goal was to define the factors related to the development of LMS and to evaluate the difference according to tumor location.
METHODS: The authors retrospectively analyzed 242 patients who had undergone resection for brain metastases. The factors investigated included tumor location with proximity to the CSF pathway (that is, contacting, involved with, or separated from the CSF pathway), the method of resection, and the use of the Cavitron Ultrasonic Surgical Aspirator (CUSA).
RESULTS: A total of 39 patients (16%) developed LMS at a median of 6.0 months (range 1-42 months) after resection. The risk of developing LMS was significantly higher in patients whose tumors were resected piecemeal than in those whose tumors were removed en bloc, with a hazard ratio (HR) of 4.08 (p < 0.01). The incidence of LMS was significantly higher in patients in whom the CUSA was used, and the HR was 2.64 (p < 0.01). The proximity of tumor to the CSF pathway in the involved group conferred an increased risk of LMS compared with the separated group (HR 11.36, p < 0.01). The risk of piecemeal resection for LMS was significant only in involved lesions (p < 0.01), and the use of the CUSA in both contact and involved lesions increased the incidence of LMS (p < 0.01 and p < 0.03, respectively).
CONCLUSIONS: The authors suggest that piecemeal resection using the CUSA should be limited because of the risk of postsurgical LMS, especially when the tumor is in contact with the CSF pathway.

Entities:  

Mesh:

Year:  2012        PMID: 22339161     DOI: 10.3171/2012.1.JNS111560

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  26 in total

1.  Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery.

Authors:  Hideyuki Arita; Yoshitaka Narita; Yasuji Miyakita; Makoto Ohno; Minako Sumi; Soichiro Shibui
Journal:  J Neurooncol       Date:  2013-10-25       Impact factor: 4.130

Review 2.  Breast leptomeningeal disease: a review of current practices and updates on management.

Authors:  Nicholas B Figura; Victoria T Rizk; Avan J Armaghani; John A Arrington; Arnold B Etame; Hyo S Han; Brian J Czerniecki; Peter A Forsyth; Kamran A Ahmed
Journal:  Breast Cancer Res Treat       Date:  2019-06-17       Impact factor: 4.872

Review 3.  Current Treatment Options for Breast Cancer Brain Metastases.

Authors:  Arrvind Raghunath; Kunal Desai; Manmeet S Ahluwalia
Journal:  Curr Treat Options Oncol       Date:  2019-02-15

4.  Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors.

Authors:  Yurday Ozdemir; Berna Akkus Yildirim; Erkan Topkan
Journal:  J Neurooncol       Date:  2016-06-15       Impact factor: 4.130

Review 5.  Neuro-ophthalmologic complications of neoplastic leptomeningeal disease.

Authors:  Gabriella Szatmáry
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

Review 6.  Neoadjuvant Stereotactic Radiosurgery: a Further Evolution in the Management of Brain Metastases.

Authors:  Cristian Udovicich; Claire Phillips; David L Kok; Damien Tange; Nikki M Plumridge; Roshan S Prabhu; Neda Haghighi
Journal:  Curr Oncol Rep       Date:  2019-07-04       Impact factor: 5.075

7.  [Surgical treatment and radiation therapy of brain metastases].

Authors:  Jan P Boström; Kathleen Jetschke; Kirsten Schmieder; Irenä Us A Adamietz
Journal:  Radiologe       Date:  2021-07-16       Impact factor: 0.635

8.  Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.

Authors:  Rosaline Ma; Morgan Levy; Bin Gui; Shou-En Lu; Venkat Narra; Sharad Goyal; Shabbar Danish; Simon Hanft; Atif J Khan; Jyoti Malhotra; Sabin Motwani; Salma K Jabbour
Journal:  J Neurooncol       Date:  2017-11-20       Impact factor: 4.130

9.  Adjuvant therapy after resection of brain metastases. Frameless image-guided LINAC-based radiosurgery and stereotactic hypofractionated radiotherapy.

Authors:  J Broemme; J Abu-Isa; R Kottke; J Beck; R Wiest; M Malthaner; D Schmidhalter; A Raabe; D M Aebersold; A Pica
Journal:  Strahlenther Onkol       Date:  2013-08-11       Impact factor: 3.621

Review 10.  The Interdisciplinary Management of Brain Metastases.

Authors:  Kirsten Schmieder; Ulrich Keilholz; Stephanie Combs
Journal:  Dtsch Arztebl Int       Date:  2016-06-17       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.